Clinical Trials Sponsored by SignPath Pharma, Inc
Total 2363 results
-
Ocuphire Pharma, Inc.CompletedPresbyopiaUnited States
-
Ocuphire Pharma, Inc.CompletedMydriasis | DilationUnited States
-
Vincerx Pharma, Inc.Active, not recruitingNeoplasmsUnited States, Chile, Spain
-
Sinew Pharma Inc.Enrolling by invitation
-
CinCor Pharma, Inc.CompletedResistant HypertensionUnited States
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
FSD Pharma, Inc.TerminatedMast Cell Activation Syndrome | Mast Cell Activation Disorder IdiopathicCanada, United States
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
Sarkana Pharma IncTerminatedHealthy ParticipantsNetherlands
-
Zurex Pharma, Inc.CompletedSurgical Skin PreparationUnited States
-
Zurex Pharma, Inc.Completed
-
Acasti Pharma Inc.Active, not recruitingAtaxia TelangiectasiaCanada
-
PACT Pharma, Inc.Suspended
-
Astellas Pharma IncCompletedDe Novo Kidney Transplant PatientsChina
-
Tris Pharma, Inc.Completed
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
Epizon Pharma, Inc.CompletedEnd-Stage Renal Disease (ESRD)United States
-
Akros Pharma Inc.CompletedSkin Diseases | Psoriasis | Plaque PsoriasisUnited States, Canada, Poland
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, Netherlands, France, Italy
-
Akros Pharma Inc.TerminatedSkin Diseases | Plaque PsoriasisUnited States, Canada
-
Zurex Pharma, Inc.Completed
-
Tris Pharma, Inc.Completed
-
Tris Pharma, Inc.CompletedDiabetes Mellitus | Diabetic Neuropathies | Chronic PainFrance, Spain, Austria, United States, Denmark, Germany, Italy, Netherlands
-
Tris Pharma, Inc.CompletedNeoplasms | Pain | Chronic PainAustria, Belgium, Bulgaria, Denmark, Germany, Hungary, Poland, Romania, Serbia, Slovakia
-
Akros Pharma Inc.CompletedRheumatoid ArthritisUkraine, United States, Argentina, Bulgaria, Romania, Peru, Russian Federation, Mexico, Colombia, Poland
-
Astellas Pharma IncCompleted
-
Telios Pharma, Inc.CompletedCOVID-19 | Carcinoma | Cancer | Solid Tumor | Sars-CoV2 | Blood CancerUnited States
-
Cocrystal Pharma, Inc.CompletedChronic Hepatitis CUnited States
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Medexus Pharma, Inc.CompletedHemophilia BUnited States, France, United Kingdom, India, Israel, Italy, Poland
-
Mediti Pharma Inc.TerminatedAggression | Dementia | Psychosis | Agitation | Alzheimer DementiaUnited States, Canada
-
SupremeCure Pharma Inc.WithdrawnRefractory Solid Tumor
-
NS Pharma, Inc.Approved for marketingMuscular Dystrophy, Duchenne | DMD
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDepression | Bipolar DisorderJapan
-
Astellas Pharma IncCompletedRheumatoid ArthritisJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Panag Pharma Inc.Completed
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan
-
Ocuphire Pharma, Inc.CompletedNight Vision Complaints | Decrease in Night Vision | Disturbance; Vision, LossUnited States
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompleted
-
Tris Pharma, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
EIP Pharma IncCompletedMild Cognitive Impairment | Alzheimer's DiseaseNetherlands
-
Astellas Pharma IncCompletedRheumatoid ArthritisUnited States
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States, India, Philippines, Colombia, Mexico
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan